[1-[(2S)-2-hydroperoxy-1-hydroxy-4-oxononadecan-3-yl]oxy-2,3-dihydroxypropyl]phosphonic acid

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: [1-[(2S)-2-hydroperoxy-1-hydroxy-4-oxononadecan-3-yl]oxy-2,3-dihydroxypropyl]phosphonic acid
• 化学式: C₂₂H₄₅O₁₀P
• 分子量: 500.6
• InChiKey: RAAXWMHTGNGJSR-YPBFCJAHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  33
• 可旋转键数：
  23
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.95
• 拓扑面积：
  174
• 氢给体数：
  6
• 氢受体数：
  10

文献信息

• METHODS AND DEVICES FOR SAMPLE COLLECTION AND SAMPLE SEPARATION
  申请人：Theranos, Inc.

  公开号：EP2972184A2

  公开（公告）日：2016-01-20
• PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/DMPG, EGPG, LYSOPG AND LYSOPC AGAINST DRUGS THAT CAUSE CHANNELOPATHIES
  申请人：Signpath Pharma Inc.

  公开号：EP3151837A1

  公开（公告）日：2017-04-12
• [EN] METHODS AND DEVICES FOR SAMPLE COLLECTION AND SAMPLE SEPARATION<br/>[FR] PROCÉDÉS ET DISPOSITIFS POUR COLLECTE D'ÉCHANTILLONS ET SÉPARATION D'ÉCHANTILLONS
  申请人：THERANOS INC

  公开号：WO2014145330A2

  公开（公告）日：2014-09-18

  Methods and devices are provided for sample collection and sample separation. In one embodiment, a device is provided for use with a formed component liquid sample, the device comprising at least one sample inlet for receiving said sample; at least a first outlet for outputting only a liquid portion of the formed component liquid sample; at least a second outlet for outputting the formed component liquid sample at least a first material mixed therein.
• [EN] PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/DMPG, EGPG, LYSOPG AND LYSOPC AGAINST DRUGS THAT CAUSE CHANNELOPATHIES<br/>[FR] EFFET PROTECTEUR DE DMPC, DMPG, DMPC/DMPG, EGPG, LYSOPG ET LYSOPC CONTRE DES MÉDICAMENTS PROVOQUANT DES CANALOPATHIES
  申请人：SIGNPATH PHARMA INC

  公开号：WO2015187883A1

  公开（公告）日：2015-12-10

  The present invention includes compositions and methods for preventing one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by an active agent or a drug in a human or animal subject comprising: an amount of a lysophosphatidyl compound adapted for oral administration effective to reduce or prevent one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by the active agent or drug. Such compositions may further comprise a monoglyceride, a free fatty acid or a combination of the foregoing, including, e.g., a eutectic mixture.
• [EN] METHODS AND DEVICES FOR SAMPLE COLLECTION AND SAMPLE SEPARATION<br/>[FR] PROCÉDÉS ET DISPOSITIFS DE COLLECTE ET DE SÉPARATION D'ÉCHANTILLONS
  申请人：THERANOS INC

  公开号：WO2017044888A1

  公开（公告）日：2017-03-16

  Methods and devices are provided for sample collection and sample separation. In one embodiment, a device is provided for use with a formed component liquid sample, the device comprising at least one sample inlet for receiving said sample; at least a first outlet for outputting only a liquid portion of the formed component liquid sample; at least a second outlet for outputting the formed component liquid sample at least a first material mixed therein.